Legal & General Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-46,449
Closed -$7.99M 3608
2021
Q3
$7.99M Buy
46,449
+8,549
+23% +$1.47M ﹤0.01% 1291
2021
Q2
$4.76M Buy
37,900
+3,069
+9% +$385K ﹤0.01% 1555
2021
Q1
$4.72M Buy
34,831
+630
+2% +$85.4K ﹤0.01% 1580
2020
Q4
$4.38M Sell
34,201
-6,170
-15% -$789K ﹤0.01% 1525
2020
Q3
$4.54M Buy
40,371
+2,104
+5% +$237K ﹤0.01% 1378
2020
Q2
$3.65M Buy
38,267
+10,329
+37% +$984K ﹤0.01% 1457
2020
Q1
$2.51M Buy
27,938
+1,687
+6% +$152K ﹤0.01% 1473
2019
Q4
$1.39M Buy
26,251
+3,972
+18% +$210K ﹤0.01% 1945
2019
Q3
$880K Buy
22,279
+3,777
+20% +$149K ﹤0.01% 2037
2019
Q2
$760K Buy
18,502
+758
+4% +$31.1K ﹤0.01% 2041
2019
Q1
$826K Buy
17,744
+1,136
+7% +$52.9K ﹤0.01% 2026
2018
Q4
$723K Buy
16,608
+3,087
+23% +$134K ﹤0.01% 2007
2018
Q3
$774K Sell
13,521
-44
-0.3% -$2.52K ﹤0.01% 2020
2018
Q2
$658K Sell
13,565
-889
-6% -$43.1K ﹤0.01% 2045
2018
Q1
$565K Sell
14,454
-2,502
-15% -$97.8K ﹤0.01% 2088
2017
Q4
$721K Buy
16,956
+1,094
+7% +$46.5K ﹤0.01% 2006
2017
Q3
$588K Buy
15,862
+5,392
+51% +$200K ﹤0.01% 2043
2017
Q2
$318K Buy
10,470
+923
+10% +$28K ﹤0.01% 2161
2017
Q1
$252K Sell
9,547
-106
-1% -$2.8K ﹤0.01% 2190
2016
Q4
$247K Buy
9,653
+5,699
+144% +$146K ﹤0.01% 2172
2016
Q3
$144K Sell
3,954
-260
-6% -$9.47K ﹤0.01% 2118
2016
Q2
$145K Buy
4,214
+173
+4% +$5.95K ﹤0.01% 1901
2016
Q1
$109K Buy
4,041
+1,020
+34% +$27.5K ﹤0.01% 1997
2015
Q4
$147K Hold
3,021
﹤0.01% 1881
2015
Q3
$73K Hold
3,021
﹤0.01% 2228
2015
Q2
$93K Hold
3,021
﹤0.01% 2162
2015
Q1
$118K Hold
3,021
﹤0.01% 1930
2014
Q4
$117K Sell
3,021
-248
-8% -$9.61K ﹤0.01% 1862
2014
Q3
$97K Buy
+3,269
New +$97K ﹤0.01% 1902